Has Nathan Shaw, MD received payments from drug or device companies?

Yes. Drug and device makers reported $53,723 in general payments to Nathan Shaw, MD across 51 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nathan Shaw, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nathan Shaw, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nathan Shaw, MD

Urology · Washington, DCNPI 1083078166

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,000 of the $53,723 with a category attached, or 93.1%. Boston Scientific accounts for 99.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $50,277 and has fallen 98.3% since, to $843 in 2025. Among urology clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,723in general payments, 2019–2025

Across 51 payments — averaging $1053.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$53K
Immunitybio, Inc.$126
Antares Pharma, Inc.$50
Merck$47
Endo USA, Inc.$42
Novartis$32
plus $42 from 2 others

What the payments were for

Consulting fees$4501%
Grants$50,00093%
Food & beverage$3,2736%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	40	$53,383
Immunitybio, Inc.	2	$126
Antares Pharma, Inc.	2	$50
Merck	2	$47
Endo USA, Inc.	2	$42
Novartis	1	$32
Olympus America Inc.	1	$27
Cook Medical LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,723 in reported general payments places this provider in the 95th percentile of 47 urology providers in District of Columbia.

See all urology providers in District of Columbia →

Medicare billing

Part B allowed, 2024

$132,991

Medicare patients

189

Services billed

638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	35	$21,802
Trospium Chloride ErTrospium Chloride	11	$2,808
Testosterone	16	$2,333
Methenamine Hippurate	31	$1,367
Trospium Chloride	16	$1,137
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	17	$684
Tamsulosin Hcl	33	$334

Paid to pharmacies, not to this prescriber.

Other urology in Washington

Armine SmithWashington$58K
Lambros StamatakisWashington$39K
Patrick MufarrijWashington$31K
Ryan HankinsWashington$29K
Adam MetwalliWashington$27K
Michael WhalenWashington$17K
Pamela ColemanWashington$14K
Leslie DeaneWashington$13K
Jason EngelWashington$12K
Keith KowalczykWashington$11K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →